STOCK TITAN

Planned $646,757.50 PAHC (NASDAQ: PAHC) share sale disclosed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of PAHC has filed a notice of proposed sale under Rule 144 for 12,528 Class A shares. The planned sale, through Fidelity Brokerage Services LLC on the NASDAQ, has an aggregate market value of $646,757.50 based on the figures provided.

The shares were acquired on 02/10/2026 via restricted stock vesting from the issuer as compensation, with payment on the same date. The filing notes that 20,623,682 shares of this class were outstanding and lists an approximate sale date of 02/11/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What stock sale is disclosed for PAHC in this Form 144?

The filing discloses a planned sale of 12,528 PAHC Class A shares. The shares are proposed to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $646,757.50 based on the amounts shown in the notice.

How were the 12,528 PAHC shares being sold under Rule 144 acquired?

The 12,528 PAHC Class A shares were acquired through restricted stock vesting. The vesting occurred on 02/10/2026, with the issuer as the source and compensation listed as the nature of payment, indicating they were granted as part of a compensation arrangement.

What is the approximate value of the PAHC shares to be sold?

The aggregate market value of the PAHC shares to be sold is $646,757.50. This value corresponds to the 12,528 Class A shares listed in the Form 144 securities information table, reflecting the total market amount associated with the proposed sale.

When is the planned sale date for the PAHC Rule 144 shares?

The approximate sale date for the PAHC shares is 02/11/2026. The Form 144 indicates this date as the expected timing for the transaction on NASDAQ, following acquisition of the restricted stock through vesting on 02/10/2026.

How many PAHC Class A shares were outstanding when the Form 144 was filed?

The notice states that 20,623,682 PAHC Class A shares were outstanding. This outstanding share figure is provided in the securities information table to give context for the 12,528 shares proposed to be sold under Rule 144.

Through which broker will the PAHC Rule 144 shares be sold?

The PAHC shares are to be sold through Fidelity Brokerage Services LLC. The broker’s address is listed as 900 Salem Street, Smithfield, RI 02917, and the filing identifies NASDAQ as the securities exchange where the Class A shares would be sold.
Phibro Animal

NASDAQ:PAHC

PAHC Rankings

PAHC Latest News

PAHC Latest SEC Filings

PAHC Stock Data

2.09B
20.48M
0.81%
105.02%
2.3%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
TEANECK